| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.ACTBIO.2011.06.050 |
| P8608 | Fatcat ID | release_ko6eqkjhunf5re35ty2xs47riu |
| P932 | PMC publication ID | 3185118 |
| P698 | PubMed publication ID | 21784181 |
| P5875 | ResearchGate publication ID | 51516506 |
| P2093 | author name string | A Nair | |
| L Tang | |||
| J Shen | |||
| C-Y Ko | |||
| C C Zhang | |||
| P Lotfi | |||
| P2860 | cites work | Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds IL-8: novel mechanisms for modulation of hematopoiesis | Q72998766 |
| Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells | Q74632432 | ||
| Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord | Q78799982 | ||
| Nonhematopoietic/endothelial SSEA-1+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment | Q79143613 | ||
| Treating diseases with adult stem cells | Q79599687 | ||
| Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells | Q80436736 | ||
| Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization | Q81008614 | ||
| In search of the in vivo identity of mesenchymal stem cells | Q81485769 | ||
| In vitro dexamethasone pretreatment enhances bone formation of human mesenchymal stem cells in vivo | Q83175353 | ||
| Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway | Q24558745 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| Chemokine receptors and their role in inflammation and infectious diseases | Q28144282 | ||
| Macrophage inflammatory protein-1 | Q28267402 | ||
| Adipose-derived stem cells for regenerative medicine | Q28301763 | ||
| Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. | Q30157916 | ||
| Tissue responses to thermally-responsive hydrogel nanoparticles | Q30841863 | ||
| Aging of mesenchymal stem cell in vitro. | Q33236089 | ||
| Evaluation of Sca-1 and c-Kit as selective markers for muscle remodelling by nonhemopoietic bone marrow cells. | Q33274060 | ||
| Synthesis of hydroxypropylcellulose-poly(acrylic acid) particles with semi-interpenetrating polymer network structure | Q33365145 | ||
| Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells | Q33379930 | ||
| Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues | Q33392869 | ||
| Functional neural differentiation of human adipose tissue-derived stem cells using bFGF and forskolin | Q33557720 | ||
| Hematopoietic and endothelial differentiation of human induced pluripotent stem cells | Q34099344 | ||
| Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair | Q34422297 | ||
| IGF-1, inflammation and stem cells: interactions during muscle regeneration. | Q34444122 | ||
| Peripheral blood stem cell mobilization: the CXCR2 ligand GRObeta rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties | Q34550536 | ||
| Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis | Q34568739 | ||
| SSEA-4 identifies mesenchymal stem cells from bone marrow | Q34576375 | ||
| Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions | Q35751008 | ||
| Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting | Q35849125 | ||
| Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair | Q36437461 | ||
| Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes | Q36591589 | ||
| Challenges in tissue engineering | Q36593082 | ||
| Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts | Q36861712 | ||
| Xeno-free derivation and culture of human embryonic stem cells: current status, problems and challenges. | Q36898638 | ||
| Adult bone marrow-derived stem cells for organ regeneration and repair | Q36904778 | ||
| Bone marrow-derived stem cells in wound healing: a review | Q36922408 | ||
| The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases | Q36951804 | ||
| Therapeutic potential of stem cells in lung disease: progress and pitfalls | Q37025992 | ||
| Homing and engraftment of progenitor cells: a prerequisite for cell therapy | Q37096297 | ||
| The promise of human induced pluripotent stem cells for research and therapy | Q37242440 | ||
| Transforming growth factor-beta promotes recruitment of bone marrow cells and bone marrow-derived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells | Q37285238 | ||
| Induced pluripotent stem cells and the stability of the differentiated state | Q37306665 | ||
| Stretching the limits: stem cells in regeneration science | Q37318040 | ||
| Induced pluripotent stem cells: current progress and potential for regenerative medicine | Q37375444 | ||
| Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes | Q37492370 | ||
| Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration | Q37537193 | ||
| Drawbacks to stem cell therapy in cardiovascular diseases | Q37608599 | ||
| Mechanisms involved in the therapeutic properties of mesenchymal stem cells | Q37635499 | ||
| Species and density of implant surface chemistry affect the extent of foreign body reactions. | Q39610672 | ||
| Surface chemistry influences implant-mediated host tissue responses | Q39610775 | ||
| The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response | Q39633175 | ||
| Platelet factor 4 enhances the adhesion of normal and leukemic hematopoietic stem/progenitor cells to endothelial cells | Q40560623 | ||
| Induction of CD45 expression and proliferation in U-266 myeloma cell line by interleukin-6. | Q40996142 | ||
| Pathological axes of wound repair: gastrulation revisited. | Q41821875 | ||
| Studies of the cellular uptake of hydrogel nanospheres and microspheres by phagocytes, vascular endothelial cells, and smooth muscle cells | Q41892512 | ||
| The mechanism of PLA microparticle formation by water-in-oil-in-water solvent evaporation method | Q44001524 | ||
| Substrate-induced phenotypical change of monocytes/macrophages into myofibroblast-like cells: a new insight into the mechanism of in-stent restenosis | Q45732796 | ||
| Mesenchymal stem cells showed the highest potential for the regeneration of injured liver tissue compared with other subpopulations of the bone marrow. | Q46019012 | ||
| High-dose corticosteroids after spinal cord injury reduce neural progenitor cell proliferation | Q46052163 | ||
| Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties | Q46799141 | ||
| Host cell mobilization for in situ tissue regeneration | Q47379403 | ||
| Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. | Q47605121 | ||
| Comparative analysis of neuroectodermal differentiation capacity of human bone marrow stromal cells using various conversion protocols. | Q50940919 | ||
| Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. | Q51311685 | ||
| Bone marrow mesenchymal stem cells upregulate transient outward potassium currents in postnatal rat ventricular myocytes. | Q51769467 | ||
| High passage number of stem cells adversely affects stem cell activation and myocardial protection. | Q51776060 | ||
| The recruitment of primitive Lin(-) Sca-1(+), CD34(+), c-kit(+) and CD271(+) cells during the early intraperitoneal foreign body reaction. | Q53452623 | ||
| Effects of anti-inflammatory drugs on proliferation, cytotoxicity and osteogenesis in bone marrow mesenchymal stem cells. | Q53532850 | ||
| Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells. | Q53676801 | ||
| Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells | Q59102107 | ||
| Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings | Q61654826 | ||
| Mobilization of early hematopoietic progenitor cells with BB-10010: a genetically engineered variant of human macrophage inflammatory protein-1 alpha | Q71696880 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 11 | |
| P304 | page(s) | 3887-3895 | |
| P577 | publication date | 2011-07-13 | |
| P1433 | published in | Acta Biomaterialia | Q4676719 |
| P1476 | title | Biomaterial implants mediate autologous stem cell recruitment in mice | |
| P478 | volume | 7 |
| Q41222578 | Alternative strategies to manipulate fibrocyte involvement in the fibrotic tissue response: pharmacokinetic inhibition and the feasibility of directed-adipogenic differentiation |
| Q90207844 | Chemokine releasing particle implants for trapping circulating prostate cancer cells |
| Q51543100 | Covalent immobilization of stem cell inducing/recruiting factor and heparin on cell-free small-diameter vascular graft for accelerated in situ tissue regeneration. |
| Q92611003 | Development of a dual-wavelength fluorescent nanoprobe for in vivo and in vitro cell tracking consecutively |
| Q33700270 | Development of optical probes for in vivo imaging of polarized macrophages during foreign body reactions |
| Q33752781 | Effect of pore structure of macroporous poly(lactide-co-glycolide) scaffolds on the in vivo enrichment of dendritic cells. |
| Q33686400 | Effects of nanoporous alumina on inflammatory cell response |
| Q34419883 | In situ re-endothelialization via multifunctional nanoscaffolds |
| Q43662865 | In vivo engineering of bone tissues with hematopoietic functions and mixed chimerism |
| Q41277215 | Macrophage interactions with polylactic acid and chitosan scaffolds lead to improved recruitment of human mesenchymal stem/stromal cells: a comprehensive study with different immune cells. |
| Q34164266 | Magnesium-containing nanostructured hybrid scaffolds for enhanced dentin regeneration |
| Q36145514 | Novel source of human hematopoietic stem cells from peritoneal dialysis effluents |
| Q53628933 | Stem cell recruitment, angiogenesis, and tissue regeneration in substance P-conjugated poly(l-lactide-co-ɛ-caprolactone) nonwoven meshes. |
| Q39452218 | Strategies to develop endogenous stem cell-recruiting bioactive materials for tissue repair and regeneration. |
| Q59059291 | The Tissue Response and Degradation of Electrospun Poly(ε-caprolactone)/Poly(trimethylene-carbonate) Scaffold in Subcutaneous Space of Mice |
| Q42286000 | The effect of erythropoietin on autologous stem cell-mediated bone regeneration |
| Q39251136 | The use of chemokine-releasing tissue engineering scaffolds in a model of inflammatory response-mediated melanoma cancer metastasis |
| Q35134893 | Tissue engineering bone using autologous progenitor cells in the peritoneum |
Search more.